Back to search
FDAFDA · Food and drugs·Recall number D-0204-2025

Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93

Published January 22, 2025 · Recall initiated: December 23, 2024

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
CARDURA
Manufacturer
Viatris Inc
Distributor
USA nationwide.
UPC
0358151078936
Lot
Lot# 8182298, Exp 10/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card